The company's shares could soar in the next year, provided several things go its way. Investing in penny stocks -- companies ...

University of Kentucky Markey Cancer Center researcher Weisi Yan, M.D., Ph.D., recently shared his work on radiation therapy ...

During a live event, Barbara T. Ma, MD, MS, reviewed guidelines on management and best practices for the use of ...

Columnist Leigh Anne Nelson rethinks her MS medication, discovering a risk and navigating crucial treatment decisions with ...

The primary endpoint was functional immune tolerance, defined as off all immunosuppressive drugs 24 months after ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

(NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today ...

Higher scores on a dietary index linked to gut microbiota health are associated with slower biological aging in US adults, according to a large cross-sectional NHANES study. The findings suggest that ...

Anixa Biosciences' breast cancer vaccine elicited targeted immune responses in 70% of patients. Click here to read an ...

EXCLUSIVE: A 20-year study in the US and UK has created an online calculator that can forecast if a rare cancer will made a comeback.

New prognostic model using novel inflammatory markers helps predict in-hospital mortality in DRESS, a severe drug reaction.

During a live event, Jorge Monge, MD, discussed short and long-term adverse events associated with CAR T-cell therapy in ...